Average Co-Inventor Count = 4.00
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Huyabio International, LLC (7 from 11 patents)
2. Huya Bioscience International, LLC (4 from 5 patents)
11 patents:
1. 12465587 - Sulcardine administration for treatment of acute atrial fibrillation
2. 12390469 - SHP2 inhibitor monotherapy and uses thereof
3. 12122833 - Combination therapies of HDAC inhibitors and PD-1 inhibitors
4. 12097203 - Combination therapies comprising SHP2 inhibitors and PD-1 inhibitors
5. 11813245 - Sulcardine administration for treatment of acute atrial fibrillation
6. 11535670 - Combination therapies of HDAC inhibitors and PD-L1 inhibitors
7. 11426382 - Sulcardine salts
8. 11020374 - Sulcardine salts
9. 10385130 - Combination therapies of HDAC inhibitors and PD-1 inhibitors
10. 10385131 - Combination therapies of HDAC inhibitors and PD-L1 inhibitors
11. 10287353 - Combination therapies of HDAC inhibitors and PD-1 inhibitors